To minimize immune rejection faced by UCAR-T cells in the tumor microenvironment (TME), we overexpressed CD47, which enables tumor cells to evade immune surveillance (13), and has been shown the potential to protect CAR-T cells from clearance by macrophages and NK cells (24, 37). Here, CD47 is linked to neoplasm.